Benchmark Downgrades Exact Sciences to Hold
Portfolio Pulse from richadhand@benzinga.com
Benchmark analyst Bruce Jackson has downgraded Exact Sciences (NASDAQ:EXAS) from Buy to Hold.

August 04, 2023 | 10:51 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Exact Sciences has been downgraded from Buy to Hold by Benchmark analyst Bruce Jackson.
The downgrade from Buy to Hold by a Benchmark analyst could potentially lead to a decrease in the stock price of Exact Sciences in the short term. This is because the downgrade may be interpreted by investors as a sign of decreased confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100